Abstract:With the increment of drug-resistant bacteria and the slow development of novel antibiotics, antimicrobial peptides have gained increasing attention as a potential antibiotic alternative. They not only displayed a broad-spectrum antimicrobial activity but also were difficult to induce resistance development because of their unique membrane-lytic activity. Herein, to improve the limitations of Anoplin, the N-methyl amino acids were first used to replace the amino acids of Anoplin at sensitive enzymatic cleave sites (Leu, Ile, Lys and Arg). Afterward, the N -methylated analogs M3.6/M4.7/M5.7 with high stability were screened out and further modified by N-terminal fatty acid conjugation to develop new antimicrobial peptide analogs with both potent antimicrobial activity and high proteolytic stability, and 12 new Anoplin analogs Cn-M3.6/M4.7/M5.7 (n = 8,10,12,14) were designed and synthesized. Our results showed that compared with native Anoplin, the stability of these N-methylated lipopeptides against trypsin and chymotrypsin degradation were increased by 10(4)-10(6) times. Besides, they still possessed potent antimicrobial activity under physiological salts and serum environment. Among them, the new designed analogs C12-M3.6/M4.7/M5.7 showed the optimal antimicrobial activity, synergy and additive effects were also observed when they were combined with traditional antibiotics polymyxin B, rifampin, and kana-mycin. Moreover, they could effectively inhibit the formation of biofilms by P. aeruginosa and S. aureus. The antimicrobial mechanism studied revealed that these N-methylated lipopeptides could display a rapid bacter-icidal effect by destroying the bacterial cell membrane. Notably, no detectable resistance of these new designed peptides was developed after continuous cultured with E. coli for 20 passages. In summary, we have designed a new class of antimicrobial peptide analogs with potent antimicrobial activity and high proteolytic stability through N-methyl amino acids substitution and N-terminal fatty acid conjugation. This study also provides new ideas and methods for the modification of antimicrobial peptides in the future.

Molecular design and antibacterial activity determination of Metalnikowin-like antibacterial peptide

Design and Synthesis of New N-terminal Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent in Vitro Biological Activity.

Molecular design and antibacterial activity of cecropin-like antibacterial peptide

Design , Synthesis and Antibacterial Activity of a Novel Hybrid Antimicrobial Peptide LFM 23

Effect of N-methylated and Fatty Acid Conjugation on Analogs of Antimicrobial Peptide Anoplin.

Design, Synthesis and Antimicrobial Activity of an Hybrid Antimicrobial Peptide LFB15-MA12.

Synthesis and Antibacterial Application of Antimicrobial Peptide CLKGPIC

Manipulation of hydrophobic motifs and optimization of sequence patterns to design high stability peptides against piglet bacterial infections

Antibacterial Activities and Molecular Mechanism of Amino-Terminal Fragments from Pig Nematode Antimicrobial Peptide CP-1

[Molecular design and biological activity analysis of antimicrobial peptide RIKL]

Designing Self‐Assembling Chimeric Peptide Nanoparticles with High Stability for Combating Piglet Bacterial Infections

The Effects of Incorporation of the Counterparts and Mimics of L-lysine on the Antimicrobial Activity, Hemolytic Activity, Cytotoxicity and Tryptic Stability of Antimicrobial Peptide Polybia-Mpii.

Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG

Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2

The Molecular Design of a Recombinant Antimicrobial Peptide CP and Its in Vitro Activity

Antimicrobial Stability and Mechanism of Antimicrobial Peptide Lc-NKlysin-1a

Characterization of the Bioactivity and Mechanism of Bactenecin Derivatives Against Food-Pathogens

Antibacterial Activity and Mechanism of Action of Bovine Lactoferricin Derivatives with Symmetrical Amino Acid Sequences.

Design of a novel analogue peptide with potent antibiofilm activities against Staphylococcus aureus based upon a sapecin B-derived peptide

Development of Aromatic-Linked Diamino Acid Antimicrobial Peptide Mimics with Low Hemolytic Toxicity and Excellent Activity Against Methicillin-Resistant Staphylococcus Aureus (MRSA)

Development of a novel hybrid antimicrobial peptide for enhancing antimicrobial spectrum and potency against food-borne pathogens